Synthesis of dolichol in a polyprenol reductase mutant is restored by elevation of cis-prenyl transferase activity

被引:21
作者
Quellhorst, GJ
Hall, CW
Robbins, AR
Krag, SS
机构
[1] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOCHEM,BALTIMORE,MD 21205
[2] NIDDK,LAB CELL BIOCHEM & BIOL,NATL INST HLTH,BETHESDA,MD 20892
关键词
dolichol; polyprenol reductase; cis-prenyl transferase; Chinese hamster ovary mutant;
D O I
10.1006/abbi.1997.0141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CHB11-1-3 is a glycosylation mutant of Chinese hamster ovary (CHO) cells, isolated by screening mutagenized cells for those with decreased intracellular lysosomal enzyme activity [C. W. Hall et al. (1986) Mol. Cell. Biochem. 72, 35-45], CHB11-1-3 synthesizes the lipid polyprenol, the metabolic precursor of dolichol, rather than dolichol, indicating a defect in polyprenol reductase. This defect was demonstrated previously in Lec9 CHO mutants, and cell fusion experiments confirmed that CHB11-1-3 is a member of this complementation group, A revertant of CHB11-1-3, CHBREV, isolated for its ability to grow at 39 degrees C, synthesizes dolichol at near-normal levels. CHBREV is probably a second-site revertant, because it synthesizes three to four times as much polyprenol as CHB11-1-3 and exhibits a similar elevation in the specific activity of cis-prenyl transferase. This higher activity appears to reflect an increase in enzyme molecules rather than the presence of an activator or absence of an inhibitor. These results suggest that CHB11-1-3 is a ''K-m'' mutant, because synthesis of higher amounts of the substrate of polyprenol reductase obviates the defect. (C) 1997 Academic Press
引用
收藏
页码:19 / 26
页数:8
相关论文
共 19 条
  • [1] CHARACTERIZATION AND LOCALIZATION OF A LONG-CHAIN ISOPRENYLTRANSFERASE ACTIVITY IN PORCINE BRAIN - PROPOSED ROLE IN THE BIOSYNTHESIS OF DOLICHYL PHOSPHATE
    CRICK, DC
    RUSH, JS
    WAECHTER, CJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 57 (04) : 1354 - 1362
  • [2] CRICK DC, 1994, J BIOL CHEM, V269, P10559
  • [3] CUMMINGS RD, 1992, GLYCOCONJUGATES COMP, P333
  • [4] FOLCH J, 1957, J BIOL CHEM, V226, P497
  • [5] HALL CW, 1986, MOL CELL BIOCHEM, V72, P35
  • [6] KAIDEN A, 1991, TRENDS GLYCOSCI GLYC, V3, P275
  • [7] KRAG SS, 1979, J BIOL CHEM, V254, P9167
  • [8] KRAG SS, 1977, J BIOL CHEM, V252, P2621
  • [9] KRAG SS, 1982, J BIOL CHEM, V257, P8424
  • [10] MCLACHLAN KR, 1994, J LIPID RES, V35, P1861